DUB
The ubiquitin--proteasome system (UPS) consists of a series of enzymatic reactions wherein ubiquitin, a 76-amino-acid polypeptide, is conjugated onto specific lysine residues of a variety of protein substrates via conjugation. The fate of ubiquitinated proteins is determined by: the number of ubiquitin residues (ub-chains), the position of conjugations, and the specific branching patterns of poly-ubiquitin chains. Protein ubiquitination (Ub) is a reversible mechanism (deubiquitination) regulated by DUBs, which has emerged as a cardinal regulatory target for posttranslational modifications which, like protein phosphorylation, adds to the complexity and sensitivity of the UPS. DUBs are a class of the human family of proteases that remove ubiquitin or ubiquitin-like proteins from a variety of protein substrates. DUBs selectively cleave the isopeptide bond present at the C-terminus of ubiquitin molecule. DUBs regulate diverse cellular processes and functions including processing or removal of polyubiquitin moieties or chains on proteins, thereby altering the targeted protein’s fate with regard to either degradation by proteasome and/or differential subcellular localization. In addition, DUBs regulate gene expression, apoptosis, cell cycle, DNA repair as well as cytokine signaling.
References
1.Farshi P,et al. Expert Opin Ther Pat. 2015;25(10):1191-1208.
References
1.Farshi P,et al. Expert Opin Ther Pat. 2015;25(10):1191-1208.
Proteasome/Ubiquitin
DUB
-
Wu-5
catalog no : M37111
cas no: 2630378-05-9
Wu-5 is a potent USP10 inhibitor that inhibits FLT3 and AMPK pathways, promoting the breakdown of FLT3-ITD and inducing apoptosis. -
USP28-IN-4
catalog no : M36612
cas no: 2931509-15-6
USP28-IN-4 is a potent USP28 inhibitor with an IC50 value of 0.04 μM against USP28. USP28-IN-4 exhibits anticancer activity and inhibits USP2, USP7, USP8, USP9x, UCHL3 and UCHL5. -
USP28-IN-3
catalog no : M36611
cas no: 2931509-14-5
USP28-IN-3 is a highly selective USP28 inhibitor with an IC50 value of 0.1 μM against USP28.USP28-IN-3 exhibits anticancer activity and inhibits USP2, USP7, USP8, USP9x, UCHL3, and UCHL5. -
I-138
catalog no : M36543
cas no: 2098211-50-6
I-138 is an orally active and potent reversible inhibitor of USP1-UAF1.I-138 induces mono-ubiquitination of FANCD2 and PCNA and inhibits USP1 auto-cleavage in cells. -
USP22-IN-1
catalog no : M36501
cas no: 309735-96-4
USP22-IN-1 is a ubiquitin-specific peptidase 22 (USP22) inhibitor that can be used to treat proliferative diseases or cancer.